Skip to main content
skinEvidence: Grade B

Using Your MitoRed MitoPRO 750 for Psoriasis Treatment

Published: Last updated:

Device-specific protocol for Psoriasis using the MitoRed MitoRed MitoPRO 750 (630/660/830/850nm, 168 mW/cm²)

Your MitoRed MitoPRO 750 Protocol for Psoriasis

Wavelengths

630nm, 660nm, 830nm, 850nm

Session Time

1 min

Target Dose

9.5 J/cm²

Distance

6 inches

Frequency

3-5x/week

Timeline

4-12 weeks

Why MitoRed MitoPRO 750 for Psoriasis?

The MitoRed MitoRed MitoPRO 750 emits at 630nm and 660nm and 830nm and 850nm, which provides a excellent match for Psoriasis treatment. Research for this condition recommends 633nm, 660nm, 830nm.

At 168 mW/cm² irradiance (at the recommended distance of 6 inches), you'll need approximately 1 minutes per session to reach the target dose of 9.5 J/cm². This falls within the recommended range of 4-15 J/cm² for Psoriasis.

The MitoRed MitoPRO 750's half body coverage area makes it suitable for treating larger treatment zones. For Psoriasis, position the device at 6 inches from the target area.

MitoRed MitoPRO 750 Quick Specs

Price

$699

LEDs

150

Power

300W

FDA

Not registered

Evidence for Psoriasis

Red light therapy at 633-660nm may reduce psoriatic plaque severity by modulating T-cell inflammation and keratinocyte proliferation. Dose: 4-15 J/cm², 10-20 minutes, 3-5x/week for 4-12 weeks. Not the same as UV phototherapy (311nm). Evidence grade: B (moderate — limited but positive clinical data).

Same Condition, Different Devices

Research Basis

This content is informed by 47+ published peer-reviewed studies on photobiomodulation.